AGER and chronic myelogenous leukemia, BCR-ABL1 positive: Exploiting RAGE over-expression in cancer, they synthesized and confirmed the selectivity of multimodal nanoparticles effectively targeted at RAGE (64Cu-Cy5-G4-CML-detectable by nuclear and optical imaging), with potential implications in cancer management [116].